Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Araliadiol may promote hair growth like minoxidil without being toxic.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

New small molecule drugs could help treat hair loss.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Adenosine complex helps increase hair thickness and density in hair loss.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Alopecia areata significantly impacts patients' mental health and quality of life.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.